{
  "trial_id": "NCT05177094",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, race, body mass index (BMI), duration of diabetic peripheral neuropathic pain, type of diabetes (type 1 or type 2), glycated hemoglobin (HbA1c) level, baseline pain intensity (VAS score), use of nonpharmacologic pain-relieving therapies, history of pain medication use, Michigan Neuropathy Screening Instrument Part B score, presence of other medical conditions, history of substance use disorder, history of cancer, presence of fibromyalgia, HIV status, reproductive status (pregnant or breastfeeding).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Average Pain Intensity as Measured by the Numeric Rating Scale (NRS)",
          "baseline pain intensity (VAS score)"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "duration of diabetic peripheral neuropathic pain",
        "type of diabetes (type 1 or type 2)",
        "glycated hemoglobin (HbA1c) level",
        "use of nonpharmacologic pain-relieving therapies",
        "history of pain medication use",
        "Michigan Neuropathy Screening Instrument Part B score",
        "presence of other medical conditions",
        "history of substance use disorder",
        "history of cancer",
        "presence of fibromyalgia",
        "HIV status",
        "reproductive status (pregnant or breastfeeding)"
      ]
    },
    "processed-gen-response": "Age, sex, race, body mass index (BMI), duration of diabetic peripheral neuropathic pain, type of diabetes (type 1 or type 2), glycated hemoglobin (HbA1c) level, baseline pain intensity (VAS score), use of nonpharmacologic pain-relieving therapies, history of pain medication use, Michigan Neuropathy Screening Instrument Part B score, presence of other medical conditions, history of substance use disorder, history of cancer, presence of fibromyalgia, HIV status, reproductive status (pregnant or breastfeeding)."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Visual Analog Scale (VAS) pain value, Duration of daily pain, Michigan Neuropathy Screening Instrument Part B score, Glycated hemoglobin, Type of diabetes (Type 1 or Type 2),",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Average Pain Intensity as Measured by the Numeric Rating Scale (NRS)"
      ],
      "remaining_candidate_features": [
        "Body Mass Index",
        "Visual Analog Scale (VAS) pain value",
        "Duration of daily pain",
        "Michigan Neuropathy Screening Instrument Part B score",
        "Glycated hemoglobin",
        "Type of diabetes (Type 1 or Type 2)"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Body Mass Index, Visual Analog Scale (VAS) pain value, Duration of daily pain, Michigan Neuropathy Screening Instrument Part B score, Glycated hemoglobin, Type of diabetes (Type 1 or Type 2)"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Duration of Diabetic Peripheral Neuropathic Pain, Duration of Diabetes, Glycated Hemoglobin, Michigan Neuropathy Screening Instrument Part B Score, VAS Pain Value at Screening.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Average Pain Intensity as Measured by the Numeric Rating Scale (NRS)"
      ],
      "remaining_candidate_features": [
        "Body Mass Index",
        "Duration of Diabetic Peripheral Neuropathic Pain",
        "Duration of Diabetes",
        "Glycated Hemoglobin",
        "Michigan Neuropathy Screening Instrument Part B Score",
        "VAS Pain Value at Screening."
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Body Mass Index, Duration of Diabetic Peripheral Neuropathic Pain, Duration of Diabetes, Glycated Hemoglobin, Michigan Neuropathy Screening Instrument Part B Score, VAS Pain Value at Screening."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of diabetic peripheral neuropathic pain, duration of diabetes, glycated hemoglobin (HbA1c) level, type of diabetes, history of pain medications, presence of comorbidities, Michigan Neuropathy Screening Instrument Part B score, visual analog scale (VAS) pain value.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Average Pain Intensity as Measured by the Numeric Rating Scale (NRS)",
          "visual analog scale (VAS) pain value"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "body mass index (BMI)",
        "duration of diabetic peripheral neuropathic pain",
        "duration of diabetes",
        "glycated hemoglobin (HbA1c) level",
        "type of diabetes",
        "history of pain medications",
        "presence of comorbidities",
        "Michigan Neuropathy Screening Instrument Part B score"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of diabetic peripheral neuropathic pain, duration of diabetes, glycated hemoglobin (HbA1c) level, type of diabetes, history of pain medications, presence of comorbidities, Michigan Neuropathy Screening Instrument Part B score, visual analog scale (VAS) pain value."
  }
}